The monoclonal antibody market represents the fastest-growing segment within the pharmaceutical industry. This sector is expected to achieve a CAGR of 14% between 2006-2012, easily outstripping the 0.6% growth rate in the small molecules market. With key products forecast to record peak sales growth and the launch of new products in the next few years, this rapid expansion is set to continue.
Edit my basket
© Datamonitor 2013. All rights reserved
Terms & Conditions